Egis in the World

Our products are available in 62 countries

Click here to learn more

Pharma Company

Our activities incorporate all areas of the pharmaceutical value chain

Click here to learn more

Research & Development

Innovation is one of the pillars of our strategy. We devote more than EUR 45 million to research and development.

Click here to learn more
Own subsidiaries / Representative offices
Sales through Partners
Our People

Celebrating our company’s 110th anniversary

The predecessor of Egis Pharmaceuticals PLC, Dr Wander Pharmaceuticals and Nutriments Ltd. was registered on 19 February 1913.

More
Egis World

Dr Csaba Pácz confirmed as Commercial Director of Egis Group

The selection process for the position of Egis Group’s Commercial Director has been closed. As a result, dr Csaba Pácz remains head of the Commercial Directorate.

More
Egis World

Csaba Poroszlai is CEO of Egis Pharmaceuticals PLC

Csaba Poroszlai is confirmed CEO of the company by the Board of Directors of Egis. Balázs Vándor is appointed to the position of the Company’s Chief Financial Officer.

More
More articles

Egis in the World

Egis’ products are available in 62 countries around the world.

Egis ’products are available in 62 countries. Our portfolio consists of 642 products.  Our main focus lies on treating diseases of the cardiovascular and central nervous systems.

Learn more

A place to work

Join us!

Therapeutic areas
Therapeutic areas
Cardiovascular system
Central nervous system
Gastroenterology
Oncology
Women´s health
WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox